Prognostic significance of acute renal injury in acute tumor lysis syndrome

References

• Azoulay E, Moreau D, Alberti C, et al Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 2000;26:1817–1823.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Recher C, Alberti C, et al Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999;25:1395–1401.
   PubMed Web of Science ®Google Scholar
• Benoit DD, Hoste EA, Depuydt PO, et al Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 2005;20:552–558.
   PubMed Web of Science ®Google Scholar
• Darmon M, Thiery G, Ciroldi M, et al Should dialysis be offered to cancer patients with acute kidney injury. Intensive Care Med 2007;33:765–772.
   PubMed Web of Science ®Google Scholar
• Lanore JJ, Brunet F, Pochard F, et al Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med 1991;19:346–351.
   PubMed Web of Science ®Google Scholar
• Soares M, Salluh JI, Carvalho MS, et al Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 2006;24:4003–4010.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3–11.
   PubMed Web of Science ®Google Scholar
• Cohen LF, Balow JE, Magrath IT, et al Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 1980;68:486–491.
   PubMed Web of Science ®Google Scholar
• Davidson MB, Thakkar S, Hix JK, et al Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 2004;116:546–554.
   PubMed Web of Science ®Google Scholar
• Annemans L, Moeremans K, Lamotte M, et al Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma 2003;44:77–83.
   PubMed Web of Science ®Google Scholar
• Mato AR, Riccio BE, Qin L, et al A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma 2006;47:877–883.
   PubMed Web of Science ®Google Scholar
• Razis E, Arlin ZA, Ahmed T, et al Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta Haematol 1994;91:171–174.
   PubMed Web of Science ®Google Scholar
• Montesinos P, Lorenzo I, Martin G, et al Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica 2008;93:67–74.
   PubMed Web of Science ®Google Scholar
• Haas M, Ohler L, Watzke H, et al The spectrum of acute renal failure in tumour lysis syndrome. Nephrol Dial Transplant 1999;14:776–779.
   PubMed Web of Science ®Google Scholar
• Patte C, Sakiroglu C, Ansoborlo S, et al Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol. Ann Oncol 2002;13:789–795.
   PubMed Web of Science ®Google Scholar
• Metnitz PG, Krenn CG, Steltzer H, et al Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051–2058.
   PubMed Web of Science ®Google Scholar
• Munker R, Hill U, Jehn U, et al Renal complications in acute leukemias. Haematologica 1998;83:416–421.
   PubMed Web of Science ®Google Scholar
• Thiery G, Azoulay E, Darmon M, et al Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005;23:4406–4413.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C, Kellum JA, et al Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–R212.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001;27:1685–1688.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Zimmerman JE, Wagner DP, et al APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591–597.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Klar J, Lemeshow S, et al The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996;276:802–810.
   PubMed Web of Science ®Google Scholar
• Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957–2963.
   PubMed Web of Science ®Google Scholar
• Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481–1483.
   PubMed Web of Science ®Google Scholar
• Altman A. Acute tumor lysis syndrome. Semin Oncol 2001;28:3–8.
   PubMed Web of Science ®Google Scholar
• Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000;27:322–334.
   PubMed Web of Science ®Google Scholar
• Goldman SC. Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies. Expert Rev Anticancer Ther 2003;3:429–433.
   PubMedGoogle Scholar
• Jeha S. Tumor lysis syndrome. Semin Hematol 2001;38:4–8.
   PubMed Web of Science ®Google Scholar
• Pui CH. Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Semin Hematol 2001;38:13–21.
   PubMed Web of Science ®Google Scholar
• Kalemkerian GP, Darwish B, Varterasian ML. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med 1997;103:363–367.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006;32:3–5.
   PubMed Web of Science ®Google Scholar